|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Muscle Cell Biology, Imperial College, London, United Kingdom
2 Renal Medicine, Imprial College, London, United Kingdom
* To whom correspondence should be addressed. E-mail: g.gharios{at}imperial.ac.uk.
Because of its mechanical function, skeletal muscle is heavily influenced by the composition of its extracellular matrix (ECM). Fibrosis generated by chronic damage, such as occurs in muscular dystrophies is thus particularly disastrous in this tissue. Here, we examined the interrelationship between the muscle satellite cell and the production of collagen type I, a major component of fibrotic ECM, using both C2C12, a satellite cell-derived cell line and primary muscle satellite cells. In C2C12 cells we found that expression of collagen type I mRNA decreases substantially during skeletal muscle differentiation. On a single cell level, collagen type I and myogenin became mutually exclusive after 3 days in differentiation medium while addition of collagen markedly suppressed differentiation of C2C12 cells. Primary cultures of satellite cells associated with isolated single fibres of the young (4 weeks old) mdx dystrophic mouse and of C57Bl/10ScSn wild-type controls expressed collagen type I and type III mRNA and protein. This pattern persisted in wild-type mice at all ages. But, curiously, in older (18 months) mdx mice, although the myogenic cells continued to express type III collagen, type I expression became restricted to non-myogenic cells. These cells typically constituted part of a cellular sheet surrounding the old mdx fibres. This combination of features strongly suggests that the progression to fibrosis in dystrophic muscle involves changes in the mechanisms controlling matrix production such as to generate positive feedback that results in a reprogramming of myoblasts to a pro-fibrotic function.
This article has been cited by other articles:
![]() |
K. D. Huebner, D. S. Jassal, O. Halevy, M. Pines, and J. E. Anderson Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1550 - H1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. McLoon Focusing on fibrosis: halofuginone-induced functional improvement in the mdx mouse model of Duchenne muscular dystrophy Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1505 - H1507. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |